SCHEMBL7815912

SCHEMBL7815912

CC(C)C[C@H](N)C(=O)N(CC(O)CNS(=O)(=O)c1ccc(OOc2ccccc2)cc1)C(=O)OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.42
▸ HSP90AB1 P08238 1/20 0.42
▸ PDK1 Q15118 1/20 0.42
▸ PDK2 Q15119 1/20 0.42
▸ PDK3 Q15120 1/20 0.42
▸ PDK4 Q16654 1/20 0.42
▸ CA2 P00918 4/20 0.42
▸ CA9 Q16790 4/20 0.42
▸ ADRB1 P08588 4/20 0.42
▸ CA12 O43570 3/20 0.42
▸ CA1 P00915 3/20 0.42
▸ ADRB2 P07550 3/20 0.41
▸ LARS1 Q9P2J5 2/20 0.39
▸ MMP2 P08253 3/20 0.39
▸ ADAMTS4 O75173 3/20 0.39
▸ MMP13 P45452 3/20 0.39
▸ MMP14 P50281 2/20 0.39
▸ ADAMTS5 Q9UNA0 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.37
▸ F2 P00734 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610531 0.83 MEN1 (0.37) CA2CA1LARS1MMP2ADAMTS4
SCHEMBL7611741 0.80 ANPEP (0.39) ALDH1A1
SCHEMBL7816028 0.74 CA5A (0.56) CA1MMP13
SCHEMBL11660914 0.72 CTSK (0.43) ALDH1A1
SCHEMBL10908162 0.72 ANPEP (0.45) ALDH1A1
SCHEMBL7163920 0.71 TARS1 (0.54) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL7164038 0.69 CTSK (0.62) CA1MMP13
SCHEMBL27799677 0.69 ANPEP (0.45) ALDH1A1CYP2D6CYP2C19
SCHEMBL27473269 0.69 ANPEP (0.45) ALDH1A1
SCHEMBL7615037 0.68 CTSK (0.37) CA2CA1LARS1MMP2ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1068304-A4 TREATMENT OF PARASITIC DISEASES BY INHIBITION OF CYSTEINE PROTEASES OF THE PAPAIN SUPERFAMILY SMITHKLINE BEECHAM CORP (US) 2001-05-09 — — EP disclosed
EP-1068304-A1 TREATMENT OF PARASITIC DISEASES BY INHIBITION OF CYSTEINE PROTEASES OF THE PAPAIN SUPERFAMILY SMITHKLINE BEECHAM CORPORATION (US) 2001-01-17 — — EP disclosed
WO-1999053039-A1 TREATMENT OF PARASITIC DISEASES BY INHIBITION OF CYSTEINE PROTEASES OF THE PAPAIN SUPERFAMILY SMITHKLINE BEECHAM CORPORATION (US) 1999-10-21 — — WO disclosed
Send feedback